Dr. Divya Sehra is a highly trained gynaecologic oncologist with advanced expertise from AIIMS New Delhi, Gemelli Rome, and Rajiv Gandhi Cancer Institute. With extensive experience in robotic, laparoscopic, and complex open cancer surgeries, she is recognised for her work in cervical, ovarian, and endometrial cancers. Her academic contributions include multiple national and international publications, editorial work, and global training roles, including MRCOG Examiner in London.

Educational Qualifications:

• MCh (Gynaecologic Oncology) – AIIMS, New Delhi (2023)
• International Fellowship (Ovarian Cancer) – IRCCS Gemelli, Rome, Italy (2023)
• Fellowship (Gynae Oncology) – Rajiv Gandhi Cancer Institute, New Delhi (2018)
• MRCOG Examiner – London (2018)
• DNB (Obstetrics & Gynaecology) – National Board of Examinations (2014)
• MS (Obstetrics & Gynaecology) – VMMC & Safdarjung Hospital, New Delhi (2013)
• MBBS – VMMC & Safdarjung Hospital, New Delhi (2010)

Professional Experience:

• Currently working at Max Healthcare
• Consultant – Gynaecological Oncology, Manipal Hospital, Dwarka (2023–2025)
• Associate Consultant – Gynaecological Oncology, AIIMS New Delhi (2020–2023)
• Associate Consultant – Gynaecological Oncology, Fortis Memorial Research Institute, Gurugram (2018–2020)
• Attending Consultant – Gynaecological Oncology, Rajiv Gandhi Cancer Institute, New Delhi (2016–2018)

Professional Memberships:

• Royal College of Obstetricians and Gynaecologists (RCOG), London
• European Society of Gynaecological Oncology (ESGO)
• International Gynecologic Cancer Society (IGCS)
• Association of Gynaecologic Oncologists of India (AGOI)
• Asia-Oceania Research Organization in Genital Infection & Neoplasia
• Association of Obstetricians & Gynaecologists of Delhi

Research Papers & Publications:

• Author, “Malignant peripheral nerve sheath tumour (MPNST) of the cervix: differential diagnosis and a favourable outcome with multimodality treatment”, BMJ Case Reports (2025)
• Co-Author, “Faking death for cervical cancer awareness: Is it justified?”, Asian Pacific Journal of Cancer Prevention (2024)
• Co-Author, “Wide local excision versus simple vulvectomy in vulval intraepithelial neoplasia-3: Case report and literature review”, Journal of Colposcopy and Lower Genital Tract Pathology (2024)
• Author, “Cervical cancer advocacy: Needs more than faking death”, The Lancet Regional Health – Southeast Asia (2024)
• Co-Author, “Wide local excision versus simple vulvectomy in vulval intraepithelial neoplasia-3: Case report and literature review”, Journal of Colposcopy and Lower Genital Tract Pathology (2024)
• Author, “Artificial intelligence in cervical cancer screening”, Journal of Colposcopy and Lower Genital Tract Pathology (2023)
• Author, “Melanoma and leukaemias: What a gynaecologist should know”, Evidence-Based Practices in Obstetrics and Gynaecology, Vol. 2 (2023)
• Author, “Complete cytoreduction in advanced epithelial ovarian cancer”, Journal of Gynaecologic Surgery (2023)
• Author, “Cutaneous metastasis in epithelial ovarian cancer”, European Society of Gynaecological Oncology Abstract Book (2022)
• Guest Editor, “Preventive gynaecologic oncology”, RCOG North Zone Newsletter (2022)
• Author, “Strategies for reducing ovarian cancer in high-risk women”, RCOG North Zone Newsletter (2022)